Vaughan Roger Daniel

Professor

Associate Dean

Office of Research

Director Centre for Clinician Scientist Development (CCSD) & Centre for Quantitative Medicine (CQM)

Email

Contact: 66016863

Dr. Roger Daniel Vaughan is the Director for the Centre for Quantitative Medicine (CQM) and Centre for Clinician Scientist Development (CCSD) and he is also the Associate Dean for the Office of Research at the Duke-NUS Medical School, Singapore. Prior to that, he was the Director of Biostatistics at The Rockefeller University Hospital, and Professor at the Weill Cornell Graduate School of Medical Sciences.

Dr. Vaughan spent 25 years at Columbia University where he held several leadership positions, including Professor and Chairman of the Department of Biostatistics, Vice Dean for Academic Advancement, and Director of the Biostatistics, Epidemiology and Research Design Core for Columbia’s Clinical and Translational Science Award (CTSA). Dr. Vaughan received his MS in Mathematical Statistics and his doctorate in Biostatistics from Columbia University. He has won numerous awards for outstanding teaching, including awards from the American Statistical Association, the American Public Health Association, and The Mailman School of Public Health, as well as Columbia University’s Presidential Teaching Award. He is an active member in many professional organizations, including the New York Academy of Medicine, the American Statistical Association, and the Association for Clinical and Translational Science. He has been a leader in the American Public Health Association and currently serves as Associate Editor and Editor for Statistics and Evaluation for their flagship journal, the American Journal of Public Health.

Dr. Vaughan’s biostatistical expertise lies in methods for the analysis of clustered and correlated data, arising typically from Group- or Cluster-randomized trials, the design and analysis of Phase I to Phase III trials, analytic methods for quasi experiments, and statistical education. He is an author of more than 150 peer-reviewed articles in both biostatistical methods development and the application of statistical methods in medicine and public health.

Dr. Vaughan followed the well worn and usual career path from restoration and renovation of historic homes to biostatistics.
Prof Vaughan’s research interests include methods in Statistical Education, Clinical Scientist Training, the design and analysis of Phase I, II, and III Clinical Trials, in the Design and Analysis of Group Randomized Trials, and methods for the analysis of Correlated Data in Biology.

 

Top 10 publications

Galea S, Vaughan R. The Public Health Penalty of Attending to the Proximal. Am J Public Health. 2021;111(2): pp.193-194.

  1. Galea S, Vaughan R. Embedding prevention at the heart of the US health conversation. Am J Public Health. 2021;111(1):17–19.
  2. Becher T, Palanisamy S, Kramer D, Eljalby M, Marx S, Wibmer A, Butler S, Jiang C, Vaughan R, Schöder H, Mark A and Cohen P. Brown adipose tissue is associated with improved cardiometabolic health in humans. Nature Medicine, 2021; doi.org/10.1038/s41591-020-1126.
  3. Pressl C, Jiang C, Correa Da Rosa J, Friedrich M, Vaughan R, Freiwald W, Tobin J. Interrogating an ICD Coded Electronic Health Records Database to Characterize the Epidemiology of Prosopagnosia. JCTS,1-26. doi:10.1017/cts.2020.497.
  4. Wright M, Delacroix E, Sonneville K, Considine S, Proctor T, Steffes J, Harris D, Shone L, Woo H, Vaughan R, Grundmeier R, Fiks A, Stockwell M, Resnicow K. Reducing paediatric overweight and obesity through motivational interviewing: study protocol for a randomised controlled trial in the AAP PROS research network. BMJ Open 2020;10:e035720. doi:10.1136/ bmjopen-2019-035720.
  5. Rahman N, Bubnys A, Kandel H, Moene O, Vaughan R, Kow LM, Tabansky I, Pfaff D. "Equation representing the dark-entrained transition from inaction to action in male and female mice". Behavioural Brain Research, 392 (2020), 112673.
  6. Frew J, Jiang C, Singh N, Grand D, Navrazhina, K, Vaughan R, Krueger J. Malignancy and infection risk during adalimumab therapy in hidradenitis suppurativa. Clinical and Experimental Dermatology. 2020, doi:10.1111/ced.14264.
  7. Ostendorf B, Bilanovic J , Adaku N, Tafreshian K , Tavora B , Vaughan R. Tavazoie, S. Common germline variants of the human APOE gene modulate melanoma progression and survival. Nature Medicine, https://doi.org/10.1038/s41591-020-0879-3.
  8. Jung M, Ramanagoudr-Bhojappa R, van Twest S, Ozgur Rosti R, Murphy V, Tan W, Donovan F, Lach F, Kimble D, Jiang CS, Vaughan R, Mehta P, Pierri F, Dufour C, Auerbach A, Deans AJ, Smogorzewska A, and Chandrasekharappa S. Association of clinical severity with FANCB variant type in Fanconi anemia. Blood. 2020;135(18):1588-1602.
  9. Frew J, Jiang C, Singh N, Grand D, Navrazhina K, Vaughan R, Kruger J. Clinical Response rates, placebo response rates and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurative: A post hoc analysis of PIONEER 1 and 2 individual patient data. J Am Acad Dermatol. 2019 Dec 24 pii: S0190-9622(19)33321-3.